Guided Therapeutics (GTHP) Debt Ratio (2011 - 2025)

Guided Therapeutics has disclosed Debt Ratio across 14 years of filings, most recently posting 0.05 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.05, down 62.15% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.05 (down 62.15% YoY), and the FY2025 annual result was 0.05, down 62.15% from the prior year.
• Debt Ratio came in at 0.05 for Q4 2025 at Guided Therapeutics, down from 0.12 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.95 in Q2 2024 to a low of 0.01 in Q3 2022.
• The 4-year median for Debt Ratio is 0.11 (2025), against an average of 0.24.
• Across the five-year window, Debt Ratio tumbled 98.64% in 2021 and jumped 1160.02% in 2022, its largest moves.
• Guided Therapeutics' Debt Ratio stood at 0.05 in 2021, then tumbled by 44.9% to 0.03 in 2022, then jumped by 303.04% to 0.12 in 2024, then tumbled by 62.15% to 0.05 in 2025.
• The last three Debt Ratio figures came in at 0.05 (Q4 2025), 0.12 (Q3 2025), and 0.1 (Q2 2025), per Business Quant data.